Article in Microbiology resource announcements, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Ana Beatriz PortesLaboratory of Advanced Analysis in Biochemistry and Molecular Biology, Department of Biochemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0002-1583-7909
Pedro PanzenhagenLaboratory of Advanced Analysis in Biochemistry and Molecular Biology, Department of Biochemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0002-7287-2663
Anamaria Mota Pereira Dos SantosLaboratory of Advanced Analysis in Biochemistry and Molecular Biology, Department of Biochemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0001-6220-0321
Ana Carolina Silva de JesusLaboratory of Advanced Analysis in Biochemistry and Molecular Biology, Department of Biochemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0002-9620-8900
Alan Clavelland OchioniLaboratory of Advanced Analysis in Biochemistry and Molecular Biology, Department of Biochemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0003-0509-1477
Sheila da Silva DuqueCollection of Campylobacter, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.ORCID 0000-0002-3982-8871
Flávia Figueira AburjaileDepartment of Preventive Veterinary Medicine, Veterinary School, Federal University of Minas Gerais, Belo Horizonte, Brazil.ORCID 0000-0002-1067-1882
Vasco AzevedoLaboratory of Cellular and Molecular Genetics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.ORCID 0000-0002-4775-2280
Carlos Adam Conte JuniorLaboratory of Advanced Analysis in Biochemistry and Molecular Biology, Department of Biochemistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.ORCID 0000-0001-6133-5080
Funding
Lacrimal Gland Repair Using Progenitor CellsR01EY026202 · NEI · SCRIPPS RESEARCH INSTITUTE, THE · PI MAKARENKOVA, HELEN P. · 2016 to 2025
$5.2M
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 313119/2020-1Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) 001Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) E-26/200.891/2021Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) E-26/202.227/2018Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) E-26/204.078/2022
6 · The paper itself
Abstract
Whole-genome sequencing identified three previously unidentified multilocus sequence types of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Draft genomes of multidrug-resistant · full record | OpenQuestion